Clinical Trial Update: Dendritic Cell Immunotherapy Against Cancer Stem Cells in Glioblastoma Patients Receiving Standard Therapy [Phase 2, Phase 3]

View source ↗

Summary

A clinical trial update for a dendritic cell immunotherapy targeting cancer stem cells in glioblastoma patients undergoing standard therapy, currently recruitin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma

Drugs mentioned

• Dendritic cell immunotherapy targeting cancer stem cells

Snippet

Sponsor: Oslo University Hospital | Conditions: Glioblastoma | Phase 2, Phase 3 | Status: RECRUITING